Pharmaceutical Market India: A
Comprehensive Industry Analysis provides you with a detailed investigation of
the market size, segmentation, key players, SWOT analysis, influential
Government policies, and business and economic environments. The report is
supported by over 330 tables & figures. The Indian pharmaceutical market
(IPM) is presented as follows:
- By Company (e.g., CIPLA, SUN PHARMA, RANBAXY, PIRAMAL, ZYDUS CADILA, MANKIND, LUPIN)
- By Segment (FORMULATIONs, APIs, BIOSIMILARs, CRAMS)
- By Therapeutic Area (e.g., Cardiovascular, Diabetes, Cancer, Respiratory)
- By Disease Category (Acute, Chronic)
A wealth of financial information is
provided including:
- Up-to-date company financials, sales & revenue figures
- India GDP, economic growth, export (bulk drug, formulations) figures
- Indian health expenditure as a function of GDP
- Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
- Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/pharmaceutical-market-india-a-competitive-industry-analysis
SWOT, Economic and Business
Environment specifics include:
- Key strengths, weaknesses and threats influencing leading player position within the IPM
- Top five fastest growing Indian pharma market segments
- Top five emerging opportunities within the IPM
- Top pharmaceutical companies within the IPM by market share and revenue
- Multinational penetration into the Indian Pharma Market
- Comprehensive product portfolios, R&D activity and pipeline therapeutics
- M&A activity and future strategies of top Indian pharmacos
- Economic indicators, trade policy, merchandise and commercial trade statistics
- Gross Domestic Product of India, historic and projection analysis
- Indian economic outlook in comparison to advanced economies
This report highlights a number of
significant Indian pharmacos and gives details of their operations, products,
financials and business strategy.
- Aurobindo Pharma
- Bharat Serums and Vaccines Ltd
- Biocon Biopharmaceuticals
- Cipla
- Divis Laboratories
- Dr Reddy’s Laboratories
- Lupin
- Mankind Pharma
- Panacea Biotech
- Piramal Group
- Ranbaxy Laboratories
- Reliance Life Sciences
- Serum Institute of India
- Sun Pharmaceuticals
- Zydus Cadila
Forecast projections and future
growth rates are provided to give you a forthcoming perspective of this growing
industry. Current developments relating to patent expirations, government
funding, and regulations are discussed. The emerging trends that appear
in key sub-markets such as generics, oncology, cardiovascular, diabetes and
vaccines are elucidated and analysed.
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/168700
What you will gain:
- An in-depth understanding of the Indian biopharmaceutical market and it’s environment
- Current market facts, figures and product lines of key players in the industry
- An insight into how generic therapeutics will propagate the Indian biopharmaceutical market
- Knowledge of how the Indian biopharma market will integrate into the global healthcare market
- Information on key government policies
- Strategies on how to adapt and restructure current business models to this industry
This report will tell you if the
companies mentioned are:
- Strong, competitive players
- Pooling their resources for specific growth and therapeutic areas
- Investing strategically in R&D
- Have a history of strategic M&A activity
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Investing in the stock market was never so easy. But Trustline helped me so much that I am getting profit out of my investment
ReplyDeleteMutual Funds India
Share Market India